217 related articles for article (PubMed ID: 18976131)
1. Drug delivery strategies for improved azole antifungal action.
Yang W; Wiederhold NP; Williams RO
Expert Opin Drug Deliv; 2008 Nov; 5(11):1199-216. PubMed ID: 18976131
[TBL] [Abstract][Full Text] [Related]
2. Novel micelle formulations to increase cutaneous bioavailability of azole antifungals.
Bachhav YG; Mondon K; Kalia YN; Gurny R; Möller M
J Control Release; 2011 Jul; 153(2):126-32. PubMed ID: 21397643
[TBL] [Abstract][Full Text] [Related]
3. Nano-encapsulation of azole antifungals: potential applications to improve oral drug delivery.
Pandey R; Ahmad Z; Sharma S; Khuller GK
Int J Pharm; 2005 Sep; 301(1-2):268-76. PubMed ID: 16023808
[TBL] [Abstract][Full Text] [Related]
4. New antifungal agents.
Gupta AK; Tomas E
Dermatol Clin; 2003 Jul; 21(3):565-76. PubMed ID: 12956208
[TBL] [Abstract][Full Text] [Related]
5. Management of chronic pulmonary aspergillosis.
Izumikawa K; Tashiro M; Kohno S
Ann N Y Acad Sci; 2012 Dec; 1272():40-8. PubMed ID: 23231713
[TBL] [Abstract][Full Text] [Related]
6. Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections.
Lakhani P; Patil A; Majumdar S
J Ocul Pharmacol Ther; 2019; 35(1):6-22. PubMed ID: 30481082
[TBL] [Abstract][Full Text] [Related]
7. Management of drug and food interactions with azole antifungal agents in transplant recipients.
Dodds-Ashley E
Pharmacotherapy; 2010 Aug; 30(8):842-54. PubMed ID: 20653361
[TBL] [Abstract][Full Text] [Related]
8. Current and emerging azole antifungal agents.
Sheehan DJ; Hitchcock CA; Sibley CM
Clin Microbiol Rev; 1999 Jan; 12(1):40-79. PubMed ID: 9880474
[TBL] [Abstract][Full Text] [Related]
9. The evolution of azole compounds in antifungal chemotherapy.
Borgers M
J Chemother; 1989 Jul; 1(4 Suppl):238-40. PubMed ID: 16312384
[No Abstract] [Full Text] [Related]
10. Voriconazole: therapeutic review of a new azole antifungal.
Herbrecht R
Expert Rev Anti Infect Ther; 2004 Aug; 2(4):485-97. PubMed ID: 15482215
[TBL] [Abstract][Full Text] [Related]
11. Antifungal activity, mode of action variability, and subcellular distribution of coumarin-based antifungal azoles.
Elias R; Benhamou RI; Jaber QZ; Dorot O; Zada SL; Oved K; Pichinuk E; Fridman M
Eur J Med Chem; 2019 Oct; 179():779-790. PubMed ID: 31288127
[TBL] [Abstract][Full Text] [Related]
12. Fundamental Concepts of Azole Compounds and Triazole Antifungals: A Beginner's Review.
Martínez-Matías N; Rodríguez-Medina JR
P R Health Sci J; 2018 Sep; 37(3):135-142. PubMed ID: 30188556
[TBL] [Abstract][Full Text] [Related]
13. Medically important fungi respond to azole drugs: an update.
Zavrel M; White TC
Future Microbiol; 2015; 10(8):1355-73. PubMed ID: 26234644
[TBL] [Abstract][Full Text] [Related]
14. Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions.
Yu DT; Peterson JF; Seger DL; Gerth WC; Bates DW
Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):755-67. PubMed ID: 15654717
[TBL] [Abstract][Full Text] [Related]
15. Current approaches and future strategies for the implementation of pharmacogenomics in the clinical use of azole antifungal drugs.
García-García I; Borobia AM
Expert Opin Drug Metab Toxicol; 2021 May; 17(5):509-514. PubMed ID: 33622115
[No Abstract] [Full Text] [Related]
16. Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents.
Benitez LL; Carver PL
Drugs; 2019 Jun; 79(8):833-853. PubMed ID: 31093949
[TBL] [Abstract][Full Text] [Related]
17. Azole antifungal agents.
Bodey GP
Clin Infect Dis; 1992 Mar; 14 Suppl 1():S161-9. PubMed ID: 1314105
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of drug-drug interactions with systemic azole antifungals.
Bates DW; Yu DT
Drugs Today (Barc); 2003 Oct; 39(10):801-13. PubMed ID: 14668935
[TBL] [Abstract][Full Text] [Related]
19. Treatment of azole-resistant oropharyngeal candidiasis with topical amphotericin B.
Grim SA; Smith KM; Romanelli F; Ofotokun I
Ann Pharmacother; 2002 Sep; 36(9):1383-6. PubMed ID: 12196056
[TBL] [Abstract][Full Text] [Related]
20. New Antifungal Agents and New Formulations Against Dermatophytes.
Gupta AK; Foley KA; Versteeg SG
Mycopathologia; 2017 Feb; 182(1-2):127-141. PubMed ID: 27502503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
